Literature DB >> 3155935

Immunology of tumor infiltrating lymphocytes.

E C Holmes.   

Abstract

Frequently peripheral blood lymphocytes (PBL) do not reflect the tumor host relationship and cell mediated immunity in the PBL does not often correlate with prognosis. The tumor infiltrating lymphocytes (TIL) interact most closely with the tumor cells and are likely to more accurately reflect tumor host interactions. These studies indicate that TIL from pulmonary tumors are similar to PBL so far as their cell surface markers are concerned. The percentage of T-cells, B-cells, helper cells, suppressor cells, and NK cells are similar in the two compartments. However, the TIL are markedly suppressed in their functional capacity as measured by their proliferative and cytotoxic activity. In addition, natural killer (NK) cell activity is markedly diminished in TIL as opposed to the PBL. In addition, the direct injection of BCG into these tumors reverses this phenomenon by significantly increasing T-cell and NK cell functional activity. Thus, the microenvironment of the tumor profoundly affects the immunologic relationship between the tumor and the host.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155935      PMCID: PMC1250634          DOI: 10.1097/00000658-198502000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Functional studies on tumor-infiltrating lymphocytes in man.

Authors:  E Klein; E Svedmyr; M Jondal; F Vanky
Journal:  Isr J Med Sci       Date:  1977-07

2.  Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

Authors:  E Grimm; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

3.  Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.

Authors:  S Targan; F Dorey
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

4.  Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.

Authors:  G Y Gillespie; S W Russell
Journal:  Int J Cancer       Date:  1978-01-15       Impact factor: 7.396

5.  Universal rosetting reagent for the detection of human cell surface markers.

Authors:  L M Karavodin; S H Golub
Journal:  J Immunol Methods       Date:  1983-07-29       Impact factor: 2.303

Review 6.  Immunogenicity of tumor antigens.

Authors:  R B Herberman
Journal:  Biochim Biophys Acta       Date:  1977-12-23

7.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

8.  Intralesional BCG immunotherapy of pulmonary tumors.

Authors:  E C Holmes; K P Ramming; M E Bein; W F Coulson; C D Callery
Journal:  J Thorac Cardiovasc Surg       Date:  1979-03       Impact factor: 5.209

Review 9.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

Authors:  L J Old
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

10.  Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection.

Authors:  M Niitsuma; S H Golub; R Edelstein; E C Holmes
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

View more
  12 in total

1.  Lymphokine activated killer cell activity in patients with GI cancer.

Authors:  P O'Byrne
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

Review 2.  The colorectal cancer immune microenvironment and approach to immunotherapies.

Authors:  Minoru Koi; John M Carethers
Journal:  Future Oncol       Date:  2017-08-22       Impact factor: 3.404

3.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study.

Authors:  H P Horny; H A Horst
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

5.  Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer.

Authors:  Dong-liang Wang; Yan-yan Liu; Yuan-long Gu; Yu Qin; Hong-fei Ji; Li-hua Wu; Ning Qi; Dan Su; Sun-hui Huang; Yan-qiao Zhang
Journal:  Tumour Biol       Date:  2015-02-20

6.  General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors.

Authors:  Ozlem Canöz; Olcay Belenli; Tahír E Patiroglu
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

Review 7.  A review of the application of inflammatory biomarkers in epidemiologic cancer research.

Authors:  Darren R Brenner; Dominique Scherer; Kenneth Muir; Joellen Schildkraut; Paolo Boffetta; Margaret R Spitz; Loic Le Marchand; Andrew T Chan; Ellen L Goode; Cornelia M Ulrich; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

8.  Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.

Authors:  F Koba; T Akiyoshi; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1987-03

9.  In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial.

Authors:  J S Economou; A S Belldegrun; J Glaspy; E M Toloza; R Figlin; J Hobbs; N Meldon; R Kaboo; C L Tso; A Miller; R Lau; W McBride; R C Moen
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.

Authors:  Mingyang Lu; Bin Huang; Samir M Hanash; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.